New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Alder BioPharmaceuticals Inc.
www.alderbio.com
Latest From Alder BioPharmaceuticals Inc.
Novartis/Amgen End CNP520 Studies, Leaving Eisai/Biogen With Last BACE Inhibitor In The Clinic
An interim look at two Phase II/III trials showed the drug worsened cognition in people at high risk of developing Alzheimer's disease. This is the 16th failure of a BACE-targeting therapy.
Biohaven's Oral Rimegepant Poised To Alter Migraine Market
Clinical data on the US biotech’s oral CGRP antagonist underlines its potential to change the dynamics of the migraine sector.
Keeping Track: US Approvals For Xpovio And Xembify Highlight Short Holiday Week
The latest drug development news and highlights from our US FDA Performance Tracker.
Novartis-Amgen’s Aimovig Poised for India Debut
Novartis is planning to launch Aimovig in India after the migraine therapy was endorsed by an expert panel, but all eyes will be on pricing and how the company’s recent dispute with partner Amgen plays out.
Company Information
- Industry
-
Biotechnology
-
Large Molecule
- Antibodies
- Synthesis Technologies, Production Processes
-
Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Alder BioPharmaceuticals Inc.
- Senior Management
-
Robert W Azelby, CEO
Carlos Campoy, CFO
John A Latham, PhD, CSO
Nadia Dac, Chief Commercial Officer
Erin Lavelle, COO - Contact Info
-
Alder BioPharmaceuticals Inc.
Phone: (425) 205-2900
11804 North Creek Pkwy. S.
Bothell, WA 98011
USA
Advertisement
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alder BioPharmaceuticals Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice